P/B
2,8
SS&C Technologies Holdings
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C’s purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C’s purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.
$18.5B
Market Cap • 11/10/2026
2005
(21 years)
Founded
2010
(16 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
2,8
P/EBITDA
8
P/OCF
10
P/FCF
10,2
P/E
22,6
BVPS
28,5
EPS
3,5
Market Cap
Market Cap
18,5B
EV
25,7B
EV/Revenue
3,8
EV/EBITDA
11,1
EV/EBIT
16,1
Payout
Dividend Per Share
1,1
Dividend Yield
1,4%
Buyback Yield
5,5%
Total Yield
6,9%
Dividend Yield 5Y
1,4%
Payout
31,1%
Retained Earnings
4,6B
Profitability
Gross Margin
48,2%
EBITDA Margin
34,7%
EBIT Margin
23,8%
Net Margin
12,8%
D&A/EBITDA
0%
R&D/Revenue
7,9%
Capex/Revenue
0,7%
Capex/D&A
6,5%
Capex/OCF
2,6%
SBC/OCF
14,5%
% PPE
2,4%
% Goodwill
48,6%
ROE
12,4%
ROIC
8,5%
Growth
CAGR Revenue 5Y
6,2%
CAGR Op. Income 5Y
6%
CAGR Net Income 5Y
2,7%
CAGR EPS 5Y
4,5%
CAGR OCF 5Y
6,2%
Leverage
N.D./EBITDA
3,1
Debt/Equity
0%
Current Ratio
1,1
Quick Ratio
0,3
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!